|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
The parent
3-amino-1,2,4-benzotriazine is a precursor of
3-amino-1,2,4-benzotriazine-1,4-dioxide (Tirapazamine, SR 4233), which is a
novel promising anti-cancer drug that is highly active against solid tumors
and causing no harm to normal tissues.
This drug is now in Phase III clinical trials. With this invention a
synthesis of Tirapazamine can be achieved in two steps process starting from
nitrobenzene and guanidine followed by treatment of the coupling product with
hydrogen peroxide or oxone. Thus the discovered method provides a simple
"green" pathway for manufacturing Tirapazamine and its derivatives. This technology is claimed in
the issued United States Patent No. 7,129,349. We are seeking an industrial partner
interested in its commercialization. (Ref: J201) |
||
|
|
|
|
|
|
|
|
«Technology Transfer Office : Sponsored Projects : Dartmouth College |
|||
|
|
||||
|
11 Rope Ferry Road #6210 |
||||
|
Hanover, NH 03755-1404 |
Phone: (603) 646-3027 |
|||
|
|
|
|
Fax: (603) 646-3670 |
|